Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran

S M Mortazavi; Z Farshadzadeh; S Janabadi; M Musavi; F Shahi; M Moradi; S Khoshnood

doi:10.1016/j.nmni.2020.100779

Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran

New Microbes New Infect. 2020 Oct 10:38:100779. doi: 10.1016/j.nmni.2020.100779. eCollection 2020 Nov.

Authors

S M Mortazavi¹, Z Farshadzadeh^{2

3}, S Janabadi⁴, M Musavi¹, F Shahi^{2

3}, M Moradi^{2

3}, S Khoshnood¹

Affiliations

¹ Student Research Committee, School of Medicine, Bam University of Medical Sciences, Bam, Iran.
² Infectious and Tropical Diseases Research Center, Health Research Institute, Iran.
³ Health Research Institute of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
⁴ Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Abstract

Acinetobacter baumannii is one of the most important opportunistic challenging pathogens as a result of its ability to acquire resistance to broad range of antibiotics and cause a variety of severe nosocomial infections. We investigated the frequency of the aminoglycoside-modifying enzymes (AMEs) and oxacillinase genes among clinical isolates of A. baumannii collected from hospitalized patients in Imam Khomeini Hospital, Ahvaz city, Iran. This prospective cross-sectional study was performed on 80 clinical isolates of A. baumannii collected from patients referred to Imam Khomeini Hospital in Ahvaz, Iran. Initial identification of isolates as A. baumannii was performed using conventional bacteriologic tests, and final confirmation was carried out by PCR of bla _OXA-51-like gene and multiplex PCR of gyrB locus. MICs of different classes of antibiotics against these strains was measured by using VITEK 2 system. After extraction of genomic DNA, two groups of multidrug-resistant A. baumannii genes including AME (aadA1, aadB, aphA6 and aacC1) and oxacillinases (bla _OXA-23-like, bla _OXA-24-like, bla _OXA-51-like, bla _OXA-58-like and bla _OXA-143-like) were detected. According to antibiotic susceptibility testing, among 80 A. baumannii strains, 75 isolates (91.25%) were multidrug resistant. The results showed that colistin and tigecycline, with respective sensitivity rates of 97.5% (78/80) and 56.25% (45/80), had the highest effects. The presence of bla _OXA-51-like and gyrB genes was confirmed in all strains. Furthermore, bla _OXA-23-like and bla _OXA-24-like genes were found in 68.75% (55/80) and 20% (16/80) of isolates respectively, while no isolate harbored the bla _OXA-143-like gene. The frequency of genes encoding the AMEs including aadA1, aacC1, aphA6 and aadB were 11.25% (9/80), 16.25% (13/80), 22.5% (18/80) and 30% (24/80) respectively. Our findings indicate that the presence of the aadB and aphA6 is correlated with high resistance against amikacin and gentamicin. We found a very high resistance rate against most of the antimicrobial agents usually prescribed for severe infections caused by A. baumannii. Therefore, because of rapid emergence of resistance even for colistin or tigecycline, monotherapy should be avoided. These results show the importance of providing antibiotics correctly in intensive care units and following antibiotic stewardship protocols as the only effective strategies to attempt to control antibiotic resistance in healthcare settings.

Keywords: Acinetobacter baumannii; aminoglycoside resistance genes; carbapenem-resistant A. baumannii (CRAB); multidrug resistance (MDR); oxacillinase genes.